Novel BCMA-targeted CAR-T Cell Therapy for Multiple Myeloma
Clinical trial NCT04706936 · UNKNOWN
Trial details
- NCT number
- NCT04706936
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-01
- Primary completion
- 2023-10-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.